ICIS Events and Educational Opportunities

From our renowned Annual Conferences to engaging workshops, free webinars, and insightful reflections on past events, we offer a wide range of opportunities for anyone looking to expand their knowledge of oncological imaging.

Loading Events

« All Events

The 25th International Cancer Imaging Society Meeting and Annual Teaching Course – Abstract Presenter Booking

23rd - 25th September, 2026 7:45 AM
The Europa Hotel Belfast

Price: £95.00 – £470.00

The theme for this year’s ICIS 2026 is: The Fundamentals of Cancer Imaging with Automated Assistance.  Join us to explore how cutting-edge imaging is transforming cancer care, equipping you to see beyond the scan, make smarter clinical decisions, and deliver better patient outcomes.  This dynamic teaching course brings together innovation, expertise, and real-world insight to […]

To access this content, you must either log in or purchase Standard Membership.

Details

  • Start: September 23 - 7:45 am
  • End: September 25 - 12:00 am
  • Cost: £95.00 – £470.00
  • Event Category:

Venue

Registration options

The numbers below include tickets for this event already in your cart. Clicking "Get Tickets" will allow you to edit any existing attendee information as well as change ticket quantities.
Abstract Presenter - 1 Day
Abstract Presenter - 1 Day
£ 165.00
Unlimited
Abstract Presenter - 2 Days
Abstract Presenter - 2 Days
£ 325.00
Unlimited
Abstract Presenter - 3 Days
Abstract Presenter - 3 Days
£ 470.00
Unlimited
Event Dinner per person
Event Dinner per person
£ 95.00
Unlimited

Days to Meeting

0
Days
0
Hours
0
Minutes

Letter from our President

 

Dear Colleagues and Friends,

On behalf of the International Cancer Imaging Society (ICIS), it is my great pleasure to invite you to join us in Belfast, Northern Ireland, for ICIS 2026, our 25th Annual Teaching Course, to be hosted in collaboration with the Faculty of Radiologists & Radiation Oncologists of the Royal College of Surgeons in Ireland (RCSI).  The focus of the meeting will be

‘Fundamentals of Imaging Cancer with Automated Assistance’.

The main vision for the conference is to reaffirm the foundational principles in cancer imaging while highlighting the growing contribution of automated assistance within clinical practice. By working together with leading industrial partners, participants will gain insight into both established and emerging imaging automation techniques that are shaping the future of oncological imaging. The comprehensive programme will include keynote lectures, plenary lectures, breakout sessions, hands-on workshops and scientific presentations.

* Stay at the forefront of oncological imaging
* Network with global experts
* Gain insights into the latest advancements in cancer diagnostics and AI-driven imaging techniques
As a city renowned for its commitment to sustainability, Belfast offers an eco-conscious setting for our annual event; attendees can explore cutting-edge research while experiencing a city that prioritises environmental responsibility, aligning with the healthcare sector’s growing focus on sustainability.

We hope you will join us in Belfast for ICIS 2026!

Warmest regards,

Anju Sahdev, President, ICIS 2026

Professor of Radiology, St Bartholomew’s Hospital, London.

Learning Objectives

 

  • To understand the role of precision imaging and advanced image guided interventions in oncology.
  • To appreciate the evolving role of cancer imaging in modern clinical-radiological integrated practice, in particular the role of objective, imaging based anatomical and functional biomarkers to guide and monitor cancer treatment.
  • To recognise the significance of large objective imaging data sets for artificial intelligence based oncologic algorithms.
  • To improve clinical reporting skills through interactive case-based workshops.
  • To review recent research findings and innovations in the field of diagnostic and interventional radiology.
TimeSession
08:00 – 08:45 Registration
08:45 – 09:00
President's Welcome
A. Sahdev
09:00 – 10:30
Focus on AI in Cancer Imaging
A. Sohaib
09:00 – 09:20
Introduction to AA and AI in medical imaging. Where are we currently?
S. Harden
09:20 – 09:40
Overcoming MRI accessibility barriers in cancer imaging with cutting-edge solutions
H. Chandarana
09:40 – 10:00
Platforms for development & marketplace for AA & AI selection
K. Chiu
10:00 – 10:20
Continuous evaluation of AI systems in cancer imaging
F. Prior
10:20 – 10:30 Questions & discussion
10:30 – 11:00 Break
11:00 – 12:30
Breast and Gynaecological
S. Vinnicombe
11:00 – 11:20
Molecular imaging of breast cancer: clinical impact and correlation with other imaging modalities
M. Queiroz
11:20 – 11:40
Computer-assisted diagnosis for mammography & ultrasound
M. Kataoka
11:40 – 12:00
The dense breast problem: where next?
S. Vinnicombe
12:00 – 12:20
AI-Assisted opportunistic detection of ovarian cancer on routine body CT and MRI
G. Lin
12:20 – 12:30 Questions & discussion
11:00 – 12:30
Obstetrics and Gynaecological
R. Forstner
11:00 – 11:25
Pregnancy: novel, intrauterine treatment options for fetal tumours
T. Huisman
11:25 – 11:50
Fertility preserving treatments for gynaecological cancers
R. Forstner
11:50 – 12:00 Questions & discussion
12:00 – 12:30
Scientific Session 1
R. Gore
11:00 – 12:30 Hands-on Workshop 1: Prostate MRI and PSMA PET
J. Fütterer & M. Naik
12:30 – 13:45 Lunch & 30-minute Sponsored Symposium
13:45 – 14:15 Keynote Lecture 1: From models to agents: The next AI revolution in oncology
N. Papanikolaou
14:15 – 15:45
Staging and Treatment Planning
C. Collins
14:15 – 14:40
Prostate cancer: disease staging & treatment planning with AI
P. Asbach
14:40 – 15:05
Treatment planning for pancreatic ductal adenocarcinoma
J. Heiken
15:05 – 15:30
Image-guided oncologic treatments and guidelines
J. Fütterer
15:30 – 15:45 Questions & discussion
14:15 – 15:45
Extended Uses of AI
H. Chandarana
14:15 – 14:40
Disease-specific structured reporting & automated assistance
A. Shinagare
14:40 – 15:05
Lung cancer screening with focus on AI
S. Digumarthy
15:05 – 15:30
Liver cancer response evaluation
B. Taouli
15:30 – 15:45 Questions & discussion
15:45 – 16:15 Break
16:15 – 17:45
Paediatrics
T. Huisman
16:15 – 16:35
Bone marrow malignancies in children and adolescents
J. Carrino
16:35 – 16:55
Paediatrics: AI in paediatric oncology
M. Lequin
16:55 – 17:15
LEAT: low-grade epilepsy associated tumours
G. Morana
17:15 – 17:35
Paediatric germ cell tumours: imaging strategies for diagnosis & management
S. Voss
17:35 – 17:45 Questions & discussion
16:15 – 17:30
Local Site Level Experience with AA & AI
F. Fennessy
16:15 – 16:35
1 year experience after implementation of a structured reporting software with integrated AI for mpMRI in the daily routine
T. Persigehl
16:35 – 16:55
The Royal Marsden experience with deep resolve in MRI
G. C. Edwards
16:55 – 17:15
AI agentic system that supports MDT meetings & tumour boards
N. Papanikolaou
17:15 – 17:45
Scientific Session 2
C. Collins
16:15 – 17:45 Hands-on Workshop 2 WB-MRI Myeloma
C. Messiou & M. Koh
17:45
Welcome Reception
TimeSession
08:00 – 09:00 Registration
08:30 – 09:00 Breakfast Symposium (Sponsored)
09:00 – 10:30
Joint ICIS and FRRO Session
A. Sahdev & E. Davis
09:00 – 09:20
Imaging extranodal capsular extension in head and neck cancers
K. Bhatia
09:20 – 09:40
Mimics and rare head and neck tumours
T.T. Zhang
09:40 – 10:00
Decoding anterior tongue carcinoma beyond TNM: Indian multi-centric, real-world data on molecular profiling and immunity in relation to clinical outcome–A divide, dive deep, and conquer approach
S. Swamy
10:00 – 10:20
Unrestricted and unmonitored: Why physicians must reclaim governance of AI in imaging and oncology
D. Comeau
10:20 – 10:30 Questions & discussion
10:30 – 11:00 Break
11:00 – 11:30 Keynote Lecture 2: Cancer Imaging: The foundation supporting the pillars of cancer treatment including AI
A. Van den Abbeele
11:30 – 13:00
Hepatobiliary
J. Heiken
11:30 – 11:50
Unusual presentation of common pancreatic tumours
M. D'Onofrio
11:50 – 12:10
Diagnostic approach & pitfalls of enhancing lesions in non-cirrhotic liver
K. Elsayes
12:10 – 12:30
Cholangiocarcinoma: classification, staging & resectability assessment including liver transplantation
K. Jhaveri
12:30 – 13:00
Scientific Session 3
A. Van Den Abbeele
11:30 – 13:00
Disease Characterisation, Scoring & AA
A. Shinagare
11:30 – 11:50
ONCO-RADS
G. Petralia
11:50 – 12:10
AI-assistance for quantifying metastatic bone disease
M. Koh
12:10 – 12:30
O-RADS
A. Shinagare
12:30 – 13:00
Scientific Session 4
A. Sohaib
11:30 – 13:00 Hands-on Workshop 3: RECIST 1.1, iRECIST, CHESON & Lugano
M. Queiroz & O. Lucidarme
13:00 – 14:15 Lunch & 30-minute Sponsored Symposium
14:15 – 15:45
Treatment Response Evaluation and AA
S. Diederich
14:15 – 14:30 Gold Medal presentation
R. Reznek & A. Sahdev
14:30 – 14:50
Imaging of lymphoma & updates to the Lugano classification
M. Mayerhoefer
14:50 – 15:10
RECIST 1.1, iRECIST & CHESON
B. Gebauer
15:10 – 15:30
New methods of assessing tumour response to immunotherapy and CAR T-cell therapy: when to resist RECIST
R. Gore
15:30 – 15:45 Questions & discussion
15:45 – 16:15 Break
16:15 – 17:45
Theranostics and Molecular Imaging
W. Oyen
16:15 – 16:40
Emerging tracers for molecular imaging
W. Oyen
16:40 – 17:05
Theranostics: state of the art and new concepts
M. Hofman
17:05 – 17:30
Neuroendocrine tumours: PET/CT DOTATATE for staging and treatment planning
T. Barwick
17:30 – 17:45 Questions & discussion
16:15 – 17:45
Unravelling Immunohistochemistry for Radiologists
K. Elsayes
16:15 – 16:35
Lung cancer in the era of molecular testing
S. Digumarthy
16:35 – 16:55
Endometrial cancer & IHC
F. Fennessy
16:55 – 17:15
Role of IHC in screening, diagnosis, immunotherapy selection, treatment response assessment of abdominal tumours
R. Gore
17:15 – 17:35
IHC in HCC
W. Schima
17:35 – 17:45 Questions & discussion
16:15 – 17:45 Hands-on Workshop 4: Rectal Cancer MRI – Baseline & Post-Treatment Response Assessment
K. Jhaveri
19:30
Course Dinner at Belfast City Hall
TimeSession
09:00 – 10:30
Unusual Tumours
W. Schima
09:00 – 09:20
Uncommon primary and secondary pancreatic neoplastic lesions
M. A. Bali
09:20 – 09:40
Unusual mesenteric and colorectal lesions
W. Schima
09:40 – 10:00
Rare pelvic masses
R. Forstner
10:00 – 10:20
Rare retroperitoneal masses
C. Messiou
10:20 – 10:30 Questions & discussion
10:30 – 11:00 Break and presentation of prizes for scientific presentations & posters
11:00 – 11:30 Keynote lecture 3: Ovarian cancer screening update: where are we currently?
R. Manchanda
11:30 – 13:00
Practice Change & Clinical Trials Update
C. Messiou
11:30 – 11:50
Role of AI and breast trials AI update
S. Vinnicombe
11:50 – 12:10
Important new trials in gynaecological cancers
A. Sohaib
12:10 – 12:30
Role of advanced imaging in driving practice change in renal cancer and kidney diseases
H. Chandarana
12:30 – 12:50
Oligometastatic disease: a window of opportunity and the evidence for intervention
G. Petralia
12:50 – 13:00 Questions & discussion
11:30 – 13:00
Mimics of Malignancy
F. Fennessy
11:30 – 11:50
Mimics of gynaecological cancer
F. Fennessy
11:50 – 12:10
Mimics of lung cancer
S. Diederich
12:10 – 12:30
Mimics of bone metastases
M. Naik
12:30 – 12:50
Mimics of hepatobiliary cancers
M. D'Onofrio
12:50 – 13:00 Questions & discussion
11:30 – 13:00 Hands-on Workshop 5: Imaging and pathological correlation with cases in pancreatic cancer
C. Matos
13:00 – 14:00 Lunch
14:00 – 15:30
Treatment Complications
A. Sohaib
14:00 – 14:20
Abdominal complications of novel cancer therapies
R. Gore
14:20 – 14:40
Complications of cancer treatment in the lung
S. Diederich
14:40 – 15:00
Immunotherapy associated neurotoxicity
G. Morana
15:00 – 15:20
Efforts to improve MRI quality in cancer imaging
K. Gormly
15:20 – 15:30 Questions & discussion
15:30 Close & Thanks

Register now

The Europa Hotel Belfast

The Europa Hotel Belfast, Northern Ireland

The Europa Hotel Belfast, Northern Ireland

ICIS 2026 Essentials - About Belfast

Accreditation

Left Image

Royal College of Radiologists accreditation has been applied for.
Left Image

EACCME (European Accreditation Council for Continuing Medical Education) accreditation has been applied for.

Meet The Speakers

Prof Anju Sahdev

Prof Anju Sahdev

President

Dr Mitesh Naik

Dr Mitesh Naik

Prof Jurgen Futterer

Prof Jurgen Futterer

Prof Christina Messiou

Prof Christina Messiou

Prof Dow-Mu Koh

Prof Dow-Mu Koh

Prof

Prof. Koh obtained his primary medical degree in Singapore (1989). Following further training in internal medicine and diagnostic radiology, he was awarded the fellowship of the Royal College of Radiologist (UK) in 1996. He was appointed to the position of Consultant Radiologist in Functional Imaging at the Royal Marsden Hospital in January 2008 and was conferred the title of Professor in Functional Cancer Imaging at the Institute of Cancer Research in 2015. Prof. Koh’s current clinical and research interest is in the development and application of functional imaging techniques for tumour assessment. He has a particular interest in developing and evaluating diffusion-weighted MR imaging in the body (DWI), to enhance and improve the ability to detect and characterise tumours, as well as to monitor the effects of conventional and novel therapeutics. Prof. Koh is the Imaging Theme Lead for the National Institute of Health Research (NIHR) Biomedical Research Centre at the Royal Marsden Hospital and Institute of Cancer Research. In 2015, he was appointed a member of the National Cancer Research Institute (NCRI) Imaging Biomarker Advisory Board in the UK. In addition to his research, Prof. Koh lectures regularly at numerous conferences and courses, including the European Congress of Radiology (ECR), European School of Radiology (ESOR), European Society of Gastrointestinal and Abdominal Radiology (ESGAR), International Society of Magnetic Resonance in Medicine meetings (ISMRM) and the Radiological Society of North America (RSNA) meetings. He was named outstanding teacher by the ISMRM in 2008, 2009 and 2012. Prof. Koh was elected a Fellow of the International Cancer Imaging Society (ICIS) (2007) and appointed Honorary Treasurer of the Society in 2011. He is series organiser for the ICIS interactive courses, a hands-on teaching course; and also the course organiser of the Body DWI course on behalf of the ESMRMB School of MRI. Prof. Koh is currently an associate editor for Radiology, and also reviews regularly for other radiological and medical journals. He was awarded the Barclay Medal in 2013 for his contributions to the British Journal of Radiology. Prof. Koh has had numerous publications in peer reviewed journals and textbooks. In 2009 he co-edited a book, ‘Diffusion-weighted MRI: Applications in the Body’, published by Springer.

Dr Marcelo Queiroz

Dr Marcelo Queiroz

Prof Olivier Lucidarme

Prof Olivier Lucidarme

Deputy Editor

Dr Kartik Jhaveri

Dr Kartik Jhaveri

Prof Celso Matos

Prof Celso Matos

Vice President

Celso Matos studied medicine at the Medical School of the University of Brussels, Belgium and obtained his Medical Degree Magna Cum Laude in 1980. After a fellowship in Internal Medicine and Rheumatology at the University of Brussels, he started his fellowship in Radiology at the department of Radiology at Erasme University Hospital in Brussels, Belgium in 1983. As a board certified radiologist he joined the faculty in this department and led the MR imaging division since 1990. He became Professor of Clinical Radiology in 2001 at Erasme University Hospital. In late 2015 Celso Matos moved to Lisbon to start his current position as Head of the Imaging department at the Champalimaud Centre for the Unknown and co Director of Champalimaud Research for clinical investigation. Celso Matos has been President of the ESGAR (European Society for Abdominal and Gastrointestinal Radiology). As a radiologist he contributes to the imaging programme of several annual meetings and regularly co-organises radiological-clinical educational events. Celso Matos’ main areas of clinical and research interest are abdominal and oncologic imaging. His main focus is multidisciplinary research in pancreatic cancer and related disorders. Celso Matos has been part of the Abdominal Section of the European Radiology Editorial Board since 2014 and has been appointed Associate Editor of Radiology in November 2016.He received the European School of Radiology Best teacher Award in 2014.

Dr Hersh Chandarana

Dr Hersh Chandarana

Dr. Chandarana is a tenured Professor of Radiology, Associate Chair for Clinical and Translational Research, and physician-scientist in the Department of Radiology at the New York University Grossman School of Medicine. Dr. Chandarana has interest and experience in the development and application of advanced imaging techniques to study pathophysiology of abdominopelvic diseases, with special interest in oncologic imaging. His extensive and productive collaborative efforts with clinicians and basic scientists as well as industry scientists allows him to collaboratively address important clinical problems.

Dr Masako Kataoka

Dr Masako Kataoka

Dr Sarah Vinnicombe

Dr Sarah Vinnicombe

Dr Gigin Lin

Dr Gigin Lin

President Elect

Dr. Gigin Lin is a physician-scientist specializing in medical imaging and cancer research. He holds an M.D. from Chang Gung University and a Ph.D. in Biochemistry from the Institute of Cancer Research at the University of London. He is currently a Professor of Radiology at Chang Gung Memorial Hospital in Taiwan. His translational research bridges clinical radiology and computational sciences, focusing on AI-enabled imaging for cancer detection, treatment monitoring, and biomarker discovery. A Fellow of the International Cancer Imaging Society, he has received national awards and international recognition, including invited lectures at ISMRM and RSNA. Dr. Lin’s research integrates advanced imaging, molecular biomarkers, and artificial intelligence to improve cancer diagnosis and treatment. His work spans molecular imaging with CT, PET, and MRI to identify imaging surrogates of tumor biology; clinical metabolomics to discover novel biomarkers and therapeutic targets; and AI-driven tools such as automated tumor segmentation, radiomics analysis, and outcome prediction across multiple cancers. He has also advanced Hyperpolarised C13 MRI, developing metabolic biomarkers to enhance treatment response. Through these multidisciplinary efforts, Dr. Lin aims to translate cutting-edge imaging and computational technologies into precision oncology applications that directly impact patient care.

Thierry Huisman

Thierry Huisman

Immediate Past President

Thierry A.G.M. Huisman is the current Radiologist-in-Chief and TCH Chair of the Department of Radiology at Texas Children’s Hospital in Houston, USA. He also holds the Edward B. Singleton Chair of Radiology. He is a tenured Professor of Radiology, Pediatrics, Neurosurgery, Neurology, Obstetrics and Gynecology at Baylor College of Medicine and holds adjunct Professor Appointments at Johns Hopkins School of Medicine in Neurosurgery and Pediatrics. Before he joined TCH he served 11 years at Johns Hopkins Medicine in Baltimore. He was the Chairman of the Department of Imaging and Imaging Science at the Johns Hopkins Bayview Medical Center. In addition, he was the Director of the Division of Pediatric Radiology, Director and founder of the Division of Pediatric Neuroradiology at the Johns Hopkins Hospital in Baltimore and Co-Director of the Neurointensive Care Nursery (NICN), the Johns Hopkins Fetal Program and the Center for Translational and Molecular Imaging (CTMI). Prior to his tenure at Johns Hopkins he was the Chairman and Radiologist-in-Chief of the Department of Diagnostic Imaging at the University Children’s Hospital Zurich. He graduated cum laude from Medical School at the Erasmus University in Rotterdam, the Netherlands, before completing residencies in Radiology and Pediatrics and fellowships in Pediatric Radiology and Neuroradiology at the University Hospital Zurich, Switzerland. Dr. Huisman enjoyed a 2.5-year research sabbatical at the Massachusetts General Hospital NMR center, Harvard Medical School in Boston. His primary field of expertise and research focuses on advanced, quantitative, precision imaging in the field of Neuroradiology. He has given more than 480 invited lectures, published 430 articles and 31 reviews, 67 book chapters, 6 text books, serves on multiple scientific committees of the various radiological societies and has organized multiple national and international meetings in Europe and the USA. He has been one of the founding members of the Swiss Symposium in Pediatric Neuroradiology and the Neurointensive Care Nursery at Johns Hopkins. Dr. Huisman served as a faculty member of the AIRP course in Washington, DC (2013-2019), and is a course advisor for the IDKD course in Davos, Switzerland since 2012. Furthermore, he has built several patient and family focused multidisciplinary programs and is actively involved in mentorship programs. He is a reviewer for multiple scientific journals and is an editorial member of 5 journals. He served as president of the American Society of Pediatric Neuroradiology (2014/15) and the Eastern Neuroradiological Society (ENRS) (2020/2021), is a fellow of the International Cancer Imaging Society, the Global Newborn Society, the American College of Radiology, and the American Society Pediatric Neuroradiology. He is the elected President of the International Cancer Imaging Society, 2024-2025. Finally, he served as senior editor of the American Journal of Neuroradiology 2015-2023.

Dr Wan Hang Keith Chiu

Dr Wan Hang Keith Chiu

Prof Fred Prior

Prof Fred Prior

Dr Rosemarie Forstner

Dr Rosemarie Forstner

Dr Nikolaos Papanikolaou

Dr Nikolaos Papanikolaou

Nickolas Papanikolaou, PhD (Male), is a Principal Investigator in Oncologic Imaging at CHAMPALIMAUD FOUNDATION and research group leader of the Computational Clinical Imaging Group. He is an Affiliated Researcher at Karolinska Institute and a Senior Affiliated Researcher at the Institute of Computer Science – FORTH. Dr. Nikolaos Papanikolaou studied biomedical engineering while he obtained his Ph.D. from the Medical School of the University of Crete. He has been a research associate of the Department of Radiology, University Hospital of Heraklion, from 1999 to 2009. He has published 85 scientific papers in peer-reviewed international journals, 17 chapters in international books. At the same time, he edited a series of 3 books on Diffusion-Weighted Imaging Applications in GI, GU, and Hepatobiliary systems. He has delivered more than 100 invited lectures in international congresses and educational courses. He served as a member of the editorial board of European Radiology in the section of experimental radiology while he was a member of the abdominal subcommittee of ECR. He has been awarded two research scholarships from ECR. Finally, he is an honorary member of the Spanish Society of Gastrointestinal Radiology (SEDIA). The main focus of his research is the development and validation of imaging biomarkers on cancer applications. He recently initiated the development of a Radiomics Network comprising luminary clinical sites in the US and Europe to advance research in that area of Radiomics. He is the section editor on AI, Radiomics, and Machine Learning in Cancer Imaging, and he is chairing the e-learning subcommittee of ICIS.

Prof Patrick Asbach

Prof Patrick Asbach

Dr. Patrick Asbach is a body imaging radiologist at the Charité in Berlin, Germany. He holds a professorship in diagnostic radiology at the Freie Universität Berlin and the Humboldt Universität zu Berlin. As a committed educator, Dr. Asbach has delivered over 100 lectures at conferences worldwide, and he was scientific organizer of several workshops on urogenital imaging. He has contributed to the literature through book chapters, commentaries, editorials, and over 100 scientific papers in PubMed citable journals.

Dr Jay Heiken

Dr Jay Heiken

Dr Atul Shinagare

Dr Atul Shinagare

Prof Bachir Taouli

Prof Bachir Taouli

Honorary Secretary

John Carino

John Carino

Prof Maarten Lequin

Prof Maarten Lequin

Dr Stephan D. Voss

Dr Stephan D. Voss

Prof Thorsten Persigehl

Prof Thorsten Persigehl

Deputy Editor

Prof. Dr. Thorsten Persigehl will support the Journal Cancer Imaging as Deputy Editor from April 2024. Prof. Persigehl holds the professorship of Oncological Imaging and he is Vice-chair at the Department of Diagnostic and Interventional Radiology at the University Hospital of Cologne. The University Hospital of Cologne with his center of integrated oncology (CIO) is one of the largest comprehensive cancer centers in Germany. As part of his clinical work, he is responsible for oncological imaging in general radiology with special expertise in abdominal imaging. Recently he founded the radiological CIO (radCIO) to reflect the increasing specialization and digitalization in radiology, supported by the EU program EFRE. As part of his scientific focus, Prof. Persigehl is investigating, with funding from German Cancer Aid (DKH), how standardized reports can be created in radiology so that this data is available digitally for clinical patient care and oncological research. On the other hand, he is developing algorithms for artificial intelligence (AI) to automatically detect and segment lymph nodes in CT images, determine their anatomic localization as part of the German Research Foundation (DFG) Priority Program 2177. Another focus is on developing and testing AI algorithms that automatically search CT images for signs of an infection that could be linked to COVID-19. In the years 2010 and 2011, he stayed as postdoctoral researcher in the oncological research group of Prof. Lawrence Schwartz at Columbia University Medical Center (CUMC) in New York. Since 2017 he is elected fellow der International Cancer Imaging Society (ICIS) and since 2022 master of oncological imaging (ESOI). Prof. Persigehl is former chairman of the Oncological Working Group of the German Society of Radiology (DRG) and speaker of the Oncological Working Group (ABO) of the German Cancer Foundation (DKG). He is currently involved as author and co-author in over 180 research papers, reviews and book chapters.

Prof Annick Van den Abbeele

Prof Annick Van den Abbeele

Professor Van den Abbeele is Professor of Radiology at Harvard Medical School; Chair Emeritus, Department of Imaging, Founder and Director of the Center for Biomedical Imaging in Oncology, Dana- Farber Cancer Institute; Co-Director of the Tumor Imaging Metrics Core, Dana-Farber/Harvard Cancer Center; Chief Emeritus, Division of Cancer Imaging, Department of Radiology, Mass General Brigham; and Senior Faculty Scholar, Dana-Farber Cancer Institute and Mass General Brigham. Professor Van den Abbeele was recently elected the 2021-2022 President of the International Cancer Imaging Society (ICIS) and serves as co-Editor-in-Chief of the ICIS journal, Cancer Imaging. She is nationally and internationally known for her translational research in molecular imaging, building upon her pioneering work in using imaging to monitor target hit and response to molecularly-targeted therapy and immunotherapy in several cancers. Professor Van den Abbeele is the founder and director of the Center for Biomedical Imaging in Oncology, an integrated clinical and preclinical cancer imaging center co-located with a research-dedicated state-of-the-art cyclotron. She also co-founded and co- directs the Tumor Imaging Metrics Core now established at eight national comprehensive cancer centers. Professor Van den Abbeele has participated in multiple trials testing novel diagnostic and therapeutic agents and helped implement the field of theranostics in multiple cancers. She launched cancer imaging as a new imaging specialty, and the Cancer Imaging Program Fellowship which has grown from one fellow to nine fellows currently who are themselves creating cancer imaging divisions in their own departments. Her major areas of research include translational cancer research using molecular imaging using multidisciplinary integrated pre-clinical and clinical programs, and quantitative tumor imaging metrics. Professor Van den Abbeele is a Fellow of the American College of Radiology (FACR) and of the International Cancer Imaging Society (FICIS). She has received several awards, serves on various national and international scientific advisory boards and review panels, NCI program progress review groups, and several local, national and international committees. Professor Van den Abbeele has mentored over 200 trainees; serves as a PhD thesis advisor, reviewer and faculty mentor; has authored and co-authored more than 300 scientific articles, abstracts, educational materials, book chapters; co- edited 2 textbooks; and presented numerous lectures and workshops nationally and internationally.

Prof Mirko D'Onofrio

Prof Mirko D'Onofrio

Dr Khaled Elsayes

Dr Khaled Elsayes

Editor-in-Chief

Prof Giuseppe Petralia

Prof Giuseppe Petralia

Prof Rodney Reznek

Prof Rodney Reznek

Professor Reznek graduated with honours from the University of Cape Town in 1972, became a Fellow of the Royal College of Radiologists in 1980 and a Fellow of the Royal College of Physicians in 1990. He is the author or co-author of over 200 publications. He is a past Editor-in-Chief of Clinical Radiology, Section Editor of European Radiology, Editor of Cancer Imaging and on the editorial board of two other journals. He is co-founder and Past President of the International Cancer Imaging Society. He has served on the Education and Faculty Boards of the Royal College of Radiologists and been chairman of the Scientific Programme Committee. He has held Visiting Professorships in several countries and given eponymous lectures in the USA, China, and the UK.

Prof Marius Mayerhoefer

Prof Marius Mayerhoefer

Prof Bernhard Gebauer

Prof Bernhard Gebauer

Dr Richard Gore

Dr Richard Gore

Prof Wim Oyen

Prof Wim Oyen

Honorary Treasurer

Professor Oyen’s main research interests are molecular imaging and radionuclide therapy of cancer. He is the (co-)author of more than 700 original science and review articles in international peer-reviewed journals. He is currently actively involved in the European Association of Nuclear Medicine, the European Cancer Organisation, the Biomedical Alliance, and the Dutch Society of Nuclear Medicine. Professor Oyen also serves as Editorial Board member of various professional journal, including The Journal of Nuclear Medicine and The European Journal of Nuclear Medicine and Molecular Imaging.

Prof Michael Hofman

Prof Michael Hofman

Dr Subba Digumarthy

Dr Subba Digumarthy

Dr Fiona Fennessy

Dr Fiona Fennessy

Prof Wolfgang Schima

Prof Wolfgang Schima

Maria Antonietta Bali

Maria Antonietta Bali

Rebecca Wiles

Rebecca Wiles

Dr Stefan Diederich

Dr Stefan Diederich

Prof Giovanni Morana

Prof Giovanni Morana

Important Details

Abstracts that do not adhere to the following important points will be rejected:

  • The title should not exceed 15 words. The title should be in bold, sentence case with no full stop at the end and no underlining.
  • The abstract should not exceed 250 words.
  • Please use authors’ initials and surnames only. No full stop at the end. Underline the name of the corresponding author. A comma should separate author names. Where authors are from a number of different institutions, the appropriate institution number from the affiliation list should be given as a superscript number immediately after each author’s name, e.g.: John Smith1, Susan Jones1, Bill Fisher2. An asterisk * should be used to link the corresponding author with their email address
  • Affiliations should include institute, town and country. Where there are multiple affiliations, each should be listed as a separate paragraph. Each institute should appear in the order used against the author names (see above paragraph) and show the appropriate superscript number, e.g.:

1 University, Town, State, USA

2 University, Town, UK

2 Company, Town, Country

  • Qualifications should be omitted.
  • Do not include references, tables or figures.
  • Please do not use block capitals.

Main text

  • In structured abstracts, paragraph headings should be typed in bold with no colon at the end. Do not use the heading ‘Abstract’. Each heading should be in a separate paragraph.

Aim

Followed by regular text, on a new line and in the same format as shown above for main text.

Materials & Methods

Results

Conclusions

Consent to publish
If the abstract contains details relating to individual participants (for example a case report), written informed consent for the publication of these details must be obtained from the participants and a statement to this effect should appear at the end of the abstract. Our guidelines for consent statements can be found here: http://www.biomedcentral.com/about/editorialpolicies#Ethics. If the patient is deceased consent for publication should be obtained from the next of kin and if the patient is under 16 consent should be obtained from the parent or guardian.

You may choose among four different abstract types:
> Oral Scientific Presentation
> Oral Case Based Presentation
> Poster Scientific Presentation
> Poster Educational Presentation

Oral Scientific Presentation
The abstract should be separated into “Aim”, “Methods”, “Results” and “Conclusion”. The abstract limit is 250 words. Abstracts should not include promissory notes such as “We will provide additional data during our presentation.”  Authors of accepted oral presentations will be invited for a presentation within the Scientific Paper Sessions.  Presentation time will be 8 minutes with 2 minutes for Q&A (depending on the final program).

Oral Case Based Presentation
The abstract should have an image and three teaching points. The abstract limit is 250 words. Abstracts should not include promissory notes such as “We will provide additional data during our presentation.”  Authors of accepted oral case based presentations will be invited for a presentation within the Scientific Paper Sessions.  Presentation time will be 8 minutes with 2 minutes for Q&A (depending on the final program).

Poster Scientific Presentation
The abstract should be separated into “Aim”, “Methods”, “Results” and “Conclusion”. The abstract limit is 250 words.

Poster Educational Presentation
The abstract should be separated into “Learning Objectives”, “Content Organisation” and “Conclusion”. The abstract limit is 250 words.

Proceedings of the 24th International Cancer Imaging

Abstracts selected for presentation will be published in the Proceedings of the 24th International Cancer Imaging, given to all delegates and faculty. A downloadable version of your submission will be made available to our membership on the members only area of our website, and be available on the Cancer Imaging open access website. Authors of selected abstracts will be notified after 30 June 2025.

How to submit

It will be obligatory for all scientific presenters to be members of ICIS at the time of presentation in The Hague. The annual membership fee of €90 will be added to the scientific presenters’ fee at registration if current membership is not in place. Please note that we have a discounted trainee membership at €45 and a much reduced trainee registration fee for the course.  Membership will run for one year from date of registration; all standard member benefits will apply.

To submit your abstract, please click the link below. You’ll be redirected to Oxford Abstracts, a separate platform that we use for handling submissions. Please follow the instructions on their site to complete your submission.

Queries may be addressed to the ICIS Secretariat
Email: [email protected]

CLICK HERE for additional information.

Terms and conditions of website use
This page (together with the documents referred to on it) tells you the terms of use on which you may make use of our website www.cancerimagingsociety.org.uk (“our site”), whether as a guest or a registered user. Please read these terms of use carefully before you start to use the site. By using our site, you indicate that you accept these terms of use and that you agree to abide by them. If you do not agree to these terms of use, please refrain from using our site.
Various elements of our site are subject to additional terms and conditions, which supplement these terms. The additional terms and conditions are brought to your intention where appropriate.

Click here for additional information.